Breaking News Instant updates and real-time market news.

TIF

Tiffany

$85.65

2.64 (3.18%)

14:06
02/17/17
02/17
14:06
02/17/17
14:06

Tiffany call volume above normal and directionally bullish

Bullish option flow detected in Tiffany with 5,806 calls trading, 7x expected, and implied vol increasing over 1 point to 31.84%. 2/24 weekly 88 calls and 3/3 weekly 86.5 calls are the most active options, with total volume in those strikes near 2,400 contracts. The Put/Call Ratio is 0.37. Earnings are expected on March 17th.

TIF Tiffany
$85.65

2.64 (3.18%)

02/06/17
02/06/17
DOWNGRADE
Target $74

Neutral
Tiffany downgraded to Neutral on CEO departure, headwinds at Mizuho
As previously reported, Mizuho downgraded Tiffany to Neutral from Buy and lowered its price target to $74 from $90. Analyst Betty Chen is concerned about multiple executive changes following the CEO departure and said the company faces several near-term headwinds ranging from macro volatility in APAC and Europe, lack of visibility in the U.S. business, and diminishing commodity price benefits.
02/06/17
HSBC
02/06/17
DOWNGRADE
HSBC
Hold
Tiffany downgraded to Hold from Buy at HSBC
02/06/17
02/06/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. AutoNation (AN) downgraded to Hold from Buy at Evercore ISI with analyst Michael Montani saying calendar year 2017 is shaping up to be an investment year and reduced estimates. The analyst said the AutoNation USA brand extension strategy means fewer franchised acquisitions and more pre-open expense for this year and next. 2. LabCorp (LH) downgraded to Neutral from Outperform at Baird with analyst Whit Mayo saying he is less convinced the company can grow earnings double digits in 2017, the current valuation is above historical averages, and he does not see an M&A deal that would meaningfully alter the risk/reward. 3. Tiffany (TIF) downgraded to Neutral from Buy at Mizuho and to Hold from Buy at HSBC. 4. CVS Health (CVS) downgraded to Neutral from Overweight at Atlantic Equities. 5. NVIDIA (NVDA) downgraded to Neutral from Buy at Roth Capital with analyst Brian Alger saying he "struggles" to articulate a valuation-driven for the stock meaningfully above current trading levels. Nonetheless, the analyst expects another "outstanding result" when the company announces earnings this week. He raised his price target on the shares to $120 from $95. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
02/14/17
BOFA
02/14/17
NO CHANGE
Target $95
BOFA
Buy
Tiffany price target raised to $95 from $90 at BofA/Merrill
BofA/Merrill analyst Lorraine Hutchinson raised Tiffany's price target to $95 from $90 to reflect early signs of a turn in sales trends and margin upside potential. The analyst has a Buy rating on Tiffany shares.

TODAY'S FREE FLY STORIES

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.